Comment from Jesse Sengillo

Summary: Dr. Jesse Sengillo, a clinician at the Bascom Palmer Eye Institute, supports the Haystack Project's petition for a rulemaking framework to evaluate clinical investigations in rare diseases. He argues that traditional development paradigms often fail to account for disease-specific factors like genotype heterogeneity and variable progression rates, and advocates for a "fit-for-purpose" approach to study design.